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Abstract
Background: Insecticide treatment of nets, curtains or walls and ceilings of houses represent the primary means
for malaria prevention worldwide. Direct personal protection of individuals and households arises from deterrent
and insecticidal activities which divert or kill mosquitoes before they can feed. However, at high coverage,
community-level reductions of mosquito density and survival prevent more transmission exposure than the
personal protection acquired by using a net or living in a sprayed house.
Methods: A process-explicit simulation of malaria transmission was applied to results of 4 recent Phase II
experimental hut trials comparing a new mosaic long-lasting insecticidal net (LLIN) which combines deltamethrin
and piperonyl butoxide with another LLIN product by the same manufacturer relying on deltamethrin alone.
Results: Direct estimates of mean personal protection against insecticide-resistant vectors in Vietnam, Cameroon,
Burkina Faso and Benin revealed no clear advantage for combination LLINs over deltamethrin-only LLINs
(P = 0.973) unless both types of nets were extensively washed (Relative mean entomologic inoculation rate (EIR) ±
standard error of the mean (SEM) for users of combination nets compared to users of deltamethrin only nets =
0.853 ± 0.056, P = 0.008). However, simulations of impact at high coverage (80% use) predicted consistently better
impact for the combination net across all four sites (Relative mean EIR ± SEM in communities with combination
nets, compared with those using deltamethrin only nets = 0.613 ± 0.076, P < 0.001), regardless of whether the nets
were washed or not (P = 0.467). Nevertheless, the degree of advantage obtained with the combination varied
substantially between sites and their associated resistant vector populations.
Conclusion: Process-explicit simulations of community-level protection, parameterized using locally-relevant
experimental hut studies, should be explicitly considered when choosing vector control products for large-scale
epidemiological trials or public health programme procurement, particularly as growing insecticide resistance
necessitates the use of multiple active ingredients.
Background
Insecticide treatment of nets, curtains or walls and
ceilings of houses represent the primary means for malaria
prevention worldwide [1,2]. Direct personal protection of
individuals and households arises from deterrent and
insecticidal activities which divert or kill mosquitoes
before they can feed [3,4]. World Health Organization
Pesticide Evaluation System (WHOPES) Phase II trials to
evaluate such measures in experimental huts therefore
quantify the efficacy of such measures in terms of the
proportional reduction in the number of blood-fed
mosquitoes caught or found dead within the huts [5].
However, at high coverage, community-level suppression
of transmission is thought to be more important than per-
sonal protection because the impact of coverage among
neighbours upon mosquito density and survival prevents
more malaria transmission than using a net or living in a
sprayed house [6]. Indeed such reasoning underlies the
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prioritization of universal coverage of all age groups with
either long-lasting insecticidal nets (LLINs) or indoor
residual spraying (IRS) as a target for malaria-endemic
African countries [7,8].
WHOPES approves individual products based on
assessments of safety, efficacy and operational accept-
ability, as well as developing specifications for quality
control and international trade [5]. However, choosing
between individual products, or combinations thereof,
requires consideration of a variety of other important
factors such as cost, durability, potential to mitigate the
emergence of insecticide resistance and expected impact
upon disease transmission. While current guidelines cor-
respondingly emphasize the need to conduct large-scale
field trials of promising products at high coverage rates,
no explicit recommendation has been made about how
to evaluate and compare alternative insecticidal products
in terms of their overall potential to control malaria.
Standardized experimental hut methodologies [5,9] do
quantify personal protection in terms of proportional
reduction of blood feeding, and the insecticidal impact
that predominantly underlies communal protection [10]
in terms of the proportion of mosquitoes killed, but no
specific guidelines exist for relating these important
properties to expected overall impact.
We therefore suggest that explicitly simulating expected
community-level impacts of each of a range of products,
using data derived from comparative experimental hut
trials, may be a useful intermediate planning step between
assessing personal protective efficacy and proceeding to
large scale trials, or even directly to procurement for pub-
lic health programmes. Here we use a process-explicit
simulation of malaria transmission, which distinguishes
the impact of deterrent, as well as fast and slow-acting
insecticidal activities [10], to re-examine the outcomes of
recently published Phase II trials comparing a new LLIN
[11] product which supplements deltamethrin with piper-
onyl butoxide (PermaNet® 3.0) with a similar conventional
product by the same manufacturer (Vestergaard Frandsen
SA, Switzerland), but relying on deltamethrin alone
(PermaNet® 2.0) [12-14].
Results
Deltamethrin plus piperonyl butoxide combination LLIN
versus deltamethrin-only LLIN
Review of direct field estimates of personal protection
through experimental hut trials (Figure 1A) revealed
no clear advantage of the new combination LLIN, rela-
tive to the deltamethrin-only product, unless both had
been washed extensively. This trend is more clearly
illustrated in Figure 2A which presents the EIR experi-
enced by a combination net user relative to that
experienced by a user of a deltamethrin-only net. EIR
for users of combination nets was not lower than for
users of deltamethrin-only nets (P = 0.973) unless they
had been washed (mean relative EIR ± standard error
of the mean (SEM) = 0.853 ± 0.056, P = 0.008). In all
cases, washing attenuated personal protection but the
direct protective efficacy of the combination product
proved to be more durable (Figure 1A, 2A). Such con-
sistently better personal protection with the combina-
tion product when washed might suggest this as the
preferred LLIN. However, the case for making such a
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Figure 1 Directly estimated direct personal protection (A) and
predicted mean overall protection assuming 80% use (B)
against malaria transmission exposure for fresh and washed
specimens of deltamethrin plus piperonyl butoxide
combination LLINs and for deltamethrin-only LLINs, based on
experimental hut field trials with insecticide-resistant vector
populations from Vietnam [32], Benin [14], Cameroon and
Burkina Faso [13].
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choice becomes less clear when one considers the lack
of a clear advantage of the combination product when
freshly distributed.
By contrast, simulations of anticipated impact at 80%
use across entire communities (Figure 1B) revealed con-
sistently equivalent-or-greater community-wide mean
overall (personal plus communal) protection with the
new combination product across all four sites, regardless
of whether these LLINS were washed or not. Conven-
tional plots of overall protection (Figure 1B) under-
represent the importance of differences between such
products, especially when considering total communal
and personal protection. This is because the incremental
impact acts on the remaining residual transmission once
high coverage is achieved rather than that which
occurred at baseline. Comparing the level of residual
transmission that can be expected with the two LLIN
products when used at high coverage levels reveals a
consistent, sometimes sizable advantage (Figure 2B).
The predicted mean EIR in communities with high cov-
erage of combination nets, compared with those using
deltamethrin only nets (Figure 2) is reduced overall
(mean relative EIR ± SEM = 0.613 ± 0.076, P < 0.001),
regardless of whether the nets were washed or not (P =
0.467).
The advantage of the combination product is most
clear for the An. gambiae population in Burkina Faso
with high frequencies of the kdr L1014F resistance
allele but no known metabolic resistance, where resi-
dual transmission expected with high coverage of del-
tamethrin-only LLINs can be further reduced by a
further 2- and 5- fold if this product is replaced with
the combination product for washed and fresh nets,
respectively. By contrast, it is noteworthy that the ben-
efit of using the new combination LLIN is appreciable
for unwashed nets at the Benin site, where the least
personal and communal protection is obtained with its
conventional predecessor, but that this advantage
essentially disappears following washing. This suggests
that such combination LLINs may have limited poten-
tial for tackling malaria transmission in this areas
where combined kdr and metabolic resistance
mechanisms both occur in the local An. gambiae
population.
Discussion
PermaNet® 3.0 was developed for increased efficacy
against pyrethroid-resistant malaria vectors, when com-
pared to conventional LLINs with a single pyrethroid
active ingredient. In the example described in Figures 1
and 2, these simulations seem to suggest a far less
ambiguous choice between two LLIN products from the
same manufacturer than would be obvious from experi-
mental hut estimates of personal protection and mos-
quito mortality. At high coverage, the community-level
protection provided by LLINs is always far greater than
direct personal protection because the former reflects
the accumulated effects of repeated risk of exposure of
mosquitoes to protected humans over the long lifespan
they require to acquire, mature and then transmit
sporogonic-stage parasites [6]. Apparently modest differ-
ences between products in personal protection can
therefore result in far larger and more obvious differ-
ences in the community-level protection they can
provide.
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Figure 2 Relative residual entomological inoculation rate for
(A) individual users at negligible net coverage and (B) the
average community member at high coverage (80% use) for
deltamethrin plus piperonyl butoxide combination LLINs
compared to those with deltamethrin-only LLINs, based on
experimental hut field trials with insecticide-resistant vector
populations from Vietnam [32], Benin [14], Cameroon and
Burkina Faso [13].
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The fact that PermaNet® 3.0 not only contains the
synergist PBO on the roof, but also higher content of
the pyrethroid deltamethrin than PermaNet® 2.0 may
well contribute to the generally higher performance of
the combination nets, especially after washing. Never-
theless, even within this small set of four sites, a wide
range of predicted advantages of the combination net
product is apparent: while the results from Burkina Faso
are extremely encouraging, those from Benin with
washed nets merit equal consideration. Ultimately, this
analysis merely represents an example which should not
be over-interpreted in its own right. However, such ana-
lyses may stimulate more locally intensive and geogra-
phically extensive field investigations, complemented
with appropriate modelling analyses, of how best to
tackle insecticide resistance and malaria transmission
with vector control products combining multiple active
ingredients.
The simulations described in Figures 1 and 2 comple-
ment conventional analyses and strengthen our ability
to interpret the data in a balanced way. While such
simulations are by no means a substitute for actually
measuring these crucially important community-level
benefits in the field, to do so necessitates trials in which
the replicated experimental units are not individual
humans but rather entire communities that are large
enough to minimize the blending of treatment impacts
across space as a result of mosquito dispersal [15,16].
To our knowledge, no such large-scale trials that unam-
biguously and directly compare the epidemiological
impact of alternative products or product combinations
have been completed [1,2,17]. Furthermore, comparative
epidemiological trials on such enormous scales necessa-
rily cost millions of dollars, take several years to com-
plete, and can therefore only be undertaken for a
carefully selected minority of the most promising or
controversial products and product combinations. In the
meantime, descriptive reviews [2,17,18] remain the only
empirical experimental evidence available with which to
compare the large-scale effectiveness of alternative pro-
ducts. Faced with such a paucity of empirical evidence,
the process of selecting products for procurement by
public health programmes, and even for large-scale epi-
demiological trials, can only be enhanced by critical
assessment of such simulation results.
It should be noted, however, that such simulations of
efficacy have significant limitations [10] and represent
just one of many criteria to consider for selecting pro-
ducts for further trials or even for direct public heath
application. All mathematical models represent simpli-
fied conceptualizations of complex real-world processes
that rely on imprecise field estimates or educated
guesses to set input parameter values. Such models are
therefore, by definition, inaccurate to some degree and
some of the greatest mistakes in the history of malaria
control policy formulation [19] have been based on
upon direct interpretation of model outputs at face
value [20,21] that subsequently proved somewhat unrea-
listic [22]. Like any other simulation modelling outputs,
these predictions merely represent educated guesses,
constituting evidence for plausibility but not probability
for the predicted outcomes.
The most obvious limitation of this particular analysis
is that it does not consider the possibility that the mor-
tality and diversion parameters measured in experimen-
tal huts may change as coverage with a specific product
rises and resistance traits against relevant active ingredi-
ents become increasingly frequent. Also, both the model
and experimental hut surveys that support it, assume
that resistance traits are consistently expressed as a
fixed phenotype across all ages but this may not always
be the case for resistant vector populations [23,24]. In
this particular comparison, the predicted advantages of
PermaNet® 3.0 cannot be unambiguously attributed to
either the addition of the PBO synergist or the higher
detamethrin concentration so the potential of this pro-
duct to either retard or accelerate the emergence of pyr-
ethroid resistance remains unclear. However, it is worth
noting that the manufacturer of this particular product
claims only that PermaNet® 3.0 has greater efficacy than
its predecessor and these simulations do strengthen that
claim.
Beyond predicted efficacy and potential to mitigate
insecticide resistance, a number of equally important
factors must also be considered when selecting products
for malaria vector control, notably as cost, safety,
acceptability, durability of efficacy in the field and local
delivery system options. Simulations such as those pre-
sented here are therefore intended to complement
rather than replace existing criteria for selecting insecti-
cidal products for malaria vector control. We therefore
emphasize that this analysis is not prescriptive nor are
we recommending any of the particular products
described here: model predictions should merely be con-
sidered as part of the evidence base to be weighed up by
malaria control programmes, their funding partners,
their technical advisors and the research community
that implements large scale epidemiological trials.
Conclusion
Simulations from models such as this one [10], and also
a number of recent alternative formulations [4,25,26],
may well be useful for anticipating the likely outcome of
large-scale trials and public health programmes. Indeed
such models may be particularly useful for examining
the potential of products with non-deterrent, slow-act-
ing, contact insecticides which may provide little perso-
nal protection but excellent community-level protection
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[4,10,26]. Examples of such products include entomo-
pathogenic fungi [27], chlorfenapyr [28], bendiocarb
[29], chlorpyrifos methyl [30] and even pyrethroid-based
LLINs that have been depleted of insecticide after sev-
eral years of use [31]. We therefore conclude that model
predictions for community-level protection should be
explicitly considered as part of the evidence base when
choosing from a range of potential products for pro-
curement by malaria control programmes, or even
further large-scale trials, particularly as growing insecti-
cide resistance necessitates the use of multiple active
ingredients.
Methods
Phase II experimental hut evaluations
All four trials referred to here were conducted according
to World Health Organization guidelines [5] using stan-
dard experimental hut designs [9] in areas where trans-
mission is mediated by vector populations with
documented high frequencies of resistance to pyre-
throids. Anopheles epiroticus in Van Duc A village, Bac
Lieu province in the Mekong Delta of southern Vietnam
are known to be resistant to deltamethrin, alpha-cyper-
methrin, etofenprox and cyfluthrin, but not DDT, with
resistance associated with elevated levels of esterases
[12,32,33]. An. arabiensis in Pitoa village near Garoua,
northern Cameroon exhibits resistance to permethrin,
deltamethrin and DDT associated with elevated levels of
esterases and oxidases [13,34-36]. An. gambiae sensu
stricto in the Kou Valley in northern Bobo-Dioulasso,
Burkina Faso exhibit high levels of resistance to pyre-
throids associated with high allelic frequencies of the
kdr mutation among the both the M and S forms
[13,37]. An. gambiae s.s. in the village of Akron on the
periphery of Porto Novo, the administrative capital of
Benin [14], are comprised entirely of the M molecular
form and are resistant to both pyrethroids and DDT
[38]. Resistant kdr alleles occur at high frequency in this
part of southern Benin and metabolic resistance is also
present [38].
In all study sites, unwashed and washed (20 times
according to standard protocols [5]) PermaNet® 2.0 and
3.0 (Vestergaard Frandsen SA, Switzerland) were com-
pared to an untreated polyester net which served as the
negative control for estimating total house entry, survi-
val and feeding rates in the absence of any insecticidal
treatment. PermaNet® 2.0 is a 100% polyester LLIN [11]
coated with a target dose of 1.8 g kg-1 deltamethrin.
PermaNet® 3.0 is a mosaic-style LLIN designed for
higher efficacy against pyrethroid resistant malaria vec-
tors. Its side panels are made of deltamethrin-coated-
polyester (with a target dose of 2.8 g kg-1 of deltame-
thrin), while the top panel is made of monofilament
polyethylene fabric into which a higher dose of
deltamethrin (4 g kg-1) and a synergist, piperonyl butox-
ide (PBO) (25 g kg-1) are incorporated.
Simulating expected community-level impact based on
experimental hut trial results
Mosquito behaviour and survival were modelled as a
function of host availability and activity patterns, as well
as LLIN properties and coverage exactly as recently
described elsewhere [10]. Briefly, this hierarchical
approach [6] predicts epidemiologically relevant out-
comes such as exposure to transmission (biodemogra-
phy-epidemiology model) based on the explicit
consideration of the activity cycles of wild mosquitoes
as they sequentially engage in host-seeking, feeding,
resting, oviposition site-seeking, oviposition and back to
host-seeking again [39] (behaviour-biodemography
model). Detailed consideration of mosquito behaviour
and mortality upon encounter with individual hosts
allows simulation of the impact of ITNs upon the fora-
ging requirements and risks for mosquito populations at
the community level [6]. Impact of LLINs upon malaria
transmission intensity is estimated in terms of relative
values of the entomologic inoculation rate (EIR) experi-
enced by users and non-users, as well as the commu-
nity-wide mean, is compared with baseline conditions
with no nets [10].
The impact of both LLIN products upon malaria
transmission under coverage conditions of 80% use (Ch
= 0.8) was simulated [10] using parameters for overall
deterrence (Δh, p), as well as excess mortality occurring
before (μh, pre) and after (μh, post) feeding on the human
hosts protected by both LLIN products, were derived
directly from the raw data. Separate parameter estimates
were calculated for both types of net, both before and
after washing, consistent with existing WHO guidelines
[5] and classification systems that unambiguously assign
all mosquitoes caught in an experimental hut trial to
one of the following outcomes: deterred, killed before
feeding, killed after feeding or fed and survived [10,40].
Correspondingly, and in keeping with standard practice
[5], personal protection was calculated as the propor-
tional reduction of blood fed mosquitoes caught.
The availability of individual humans for attack by
host seeking mosquitoes, was fixed at 0.0012 attacks per
night per person per host-seeking mosquito for the Afri-
can scenarios in Benin, Burkina Faso and Cameroon
[10,41,42]. For the An. gambiae populations in Burkina
Faso and Benin, the availability of cattle to vectors was
set at 0.000025 attacks per head of cattle per night per
host-seeking mosquito while for the An arabiensis
population in Cameroon it was set at 0.0019 attacks per
head of cattle per night per host-seeking mosquito as
previously described and justified [41,42]. In order to
simulate the overwhelmingly zoophagic An. epiroticus
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population in Bac Lieu, Vietnam, the availability of cattle
was set at 0.0019, identical to An. arabiensis, and the
availability of humans calculated by dividing this value
by 11.53 based on relative availability measurements
[42,43] made in this setting by directly comparing cow
and human landing rates [44].
Statistical analysis
The level of improvement of impact achieved by repla-
cing deltamethrin-only nets with the combination pro-
duct was assessed treating the proportional reduction of
residual transmission as the dependent in a generalized
linear model in which washing regime was treated as
the only categorical factor, with no washing as the refer-
ence group and 20 washes as the test group. The depen-
dent variable was computed as one minus the relative
EIR for combination nets compared with deltamethrin-
only nets so that the intercept reflects and change rela-
tive to the deltamethrin-only nets for fresh, unwashed
nets.
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